IDDF2022-ABS-0196 The role of circulating tumor cells in peripheral blood as an adjunctive non-invasive diagnostic methods for colorectal cancer

Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality. The gold standard for diagnosing colorectal cancer is histopathology, which is obtained from a biopsy during colonoscopy. Since not all patients are willing to undergo invasive testing at the outset of the first diagnostic plan, new non-invasive approaches that can complement and enhance strategies for non-invasive diagnosis and management of colorectal cancer are urgently needed. Circulating tumor cells (CTC) in the blood are expected to be used as a non-invasive diagnostic marker in patients with CRC. This research is a diagnostic test of CTC on CRC using the isolation and analysis of the negative selection immunomagnetic method with Easysep™ and CD44 cancer mesenchymal marker.